TP53 | 7157 | 9155064 | Endometrioid type+ adenoacanthomas+ papillary serous carcinoma+ clear cell carcinoma+ papillar carcinoma+ mucinous carcinoma)   | -   | -   | -   | -   | 80 (61 endometrioid type+ 13 adenoacanthomas+ 2 papillary serous carcinoma+ clear cell carcinoma+ 1 papillar carcinoma+ 1 mucinous carcinoma)   | 45 to 82   | -   | Department of Obstetrics and Gynecology; Hospital Universitari Materno- Infantil Vall d'Hebron of Barcelona   | IA (n=13); IB (n=19); IC (n=8); IIA (n=11); IIB (n=9); IIIC (n=2)   | -   | | Susceptibility to endometrial cancer: influence of allelism at p53; glutathione S-transferase (GSTM1 and GSTT1) and cytochrome P-450 (CYP1A1) loci   | British Journal of Cancer   | 75(9):1385-8   | 1997   |
TP53 | 7157 | 15099969 | -   | Polymorphism   | -   | Tumor suppressor   | 285   | 95   | -   | -   | Department of Obstetrics and Gynecology; Seoul National University Hospital.   | IA (n=31); IB (n=34); IC (n=11); IIA (n=5); IIB (n=2); IIIA (n=4); IIIC (n=4); IVB (n=4)   | -   | | p53 and p21 genetic polymorphisms and susceptibility to endometrial cancer   | Gynecologic Oncology   | 93(2):499-505   | 2004   |